83 related articles for article (PubMed ID: 17376127)
1. Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?
Halperin A; Elstein D; Zimran A
Acta Neurol Scand; 2007 Apr; 115(4):275-8. PubMed ID: 17376127
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
Biegstraaten M; Mengel E; Maródi L; Petakov M; Niederau C; Giraldo P; Hughes D; Mrsic M; Mehta A; Hollak CE; van Schaik IN
Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.
Halperin A; Elstein D; Zimran A
Blood Cells Mol Dis; 2006; 36(3):426-8. PubMed ID: 16651014
[TBL] [Abstract][Full Text] [Related]
4. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.
Zimran A; Liphshitz I; Barchana M; Abrahamov A; Elstein D
Blood Cells Mol Dis; 2005; 34(3):197-200. PubMed ID: 15885601
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
[TBL] [Abstract][Full Text] [Related]
7. Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme.
Hollak CE; Hughes D; van Schaik IN; Schwierin B; Bembi B
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):770-7. PubMed ID: 19507165
[TBL] [Abstract][Full Text] [Related]
8. Gaucher disease in Arab patients at an Israeli referral clinic.
Brautbar A; Abrahamov A; Hadas-Halpern I; Elstein D; Zimran A
Isr Med Assoc J; 2008; 10(8-9):600-2. PubMed ID: 18847161
[TBL] [Abstract][Full Text] [Related]
9. Fibromyalgia and Gaucher's disease.
Brautbar A; Elstein D; Pines B; Krienen N; Hemmer J; Buskila D; Zimran A
QJM; 2006 Feb; 99(2):103-7. PubMed ID: 16293672
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype.
Beutler E; West C
Isr Med Assoc J; 2002 Nov; 4(11):986-8. PubMed ID: 12489486
[TBL] [Abstract][Full Text] [Related]
11. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.
Kannai R; Chertok IR
Isr Med Assoc J; 2006 May; 8(5):347-50. PubMed ID: 16805236
[TBL] [Abstract][Full Text] [Related]
12. Neurological and brain MRS findings in patients with Gaucher disease type 1.
Mercimek-Mahmutoglu S; Gruber S; Rolfs A; Stadlbauer A; Woeber C; Kurnik P; Voigtlaender T; Moser E; Stoeckler-Ipsiroglu S
Mol Genet Metab; 2007 Aug; 91(4):390-5. PubMed ID: 17560820
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of cancer in adult Gaucher disease in Western Europe.
de Fost M; Vom Dahl S; Weverling GJ; Brill N; Brett S; Häussinger D; Hollak CE
Blood Cells Mol Dis; 2006; 36(1):53-8. PubMed ID: 16246599
[TBL] [Abstract][Full Text] [Related]
14. Uveitis in Gaucher disease.
Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
[TBL] [Abstract][Full Text] [Related]
15. [Foot disease in Icelandic patients with established type 2 diabetes].
Heimisdottir F; Gudnason V; Sigurdsson G; Benediktsson R
Laeknabladid; 2008 Feb; 94(2):109-14. PubMed ID: 18310775
[TBL] [Abstract][Full Text] [Related]
16. The orthopedic aspects of Gaucher disease.
Goldblatt J; Sacks S; Beighton P
Clin Orthop Relat Res; 1978; (137):208-14. PubMed ID: 743830
[TBL] [Abstract][Full Text] [Related]
17. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Pastores GM; Elstein D; Hrebícek M; Zimran A
Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
[TBL] [Abstract][Full Text] [Related]
18. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
Piran S; Roberts A; Patterson MA; Amato D
Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
[TBL] [Abstract][Full Text] [Related]
19. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
Di Rocco M; Giona F; Carubbi F; Linari S; Minichilli F; Brady RO; Mariani G; Cappellini MD
Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565
[TBL] [Abstract][Full Text] [Related]
20. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
Kaplan P; Andersson HC; Kacena KA; Yee JD
Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
